Connect your AI

Bio-Techne TECH Operating Segments — Total Assets

Discontinued — last reported Q4 '16

Similar metrics at other companies

MTDOther Operations Segment — Total Assets

$525.14M+27.7%

WMBOther Operating Segment — Total Assets

$1.78B+42.5%

COPTotal Segments — Total Assets

$112.55B-0.4%

CATAll Other Segment — Segment assets

$1.47B-25.5%

SFAll Other Segments — Total Assets

$172.46M-13.4%

EFC

EFCCorporate Segment and Other Operating Segment — Total Assets

$157.27M-27.4%

Other financials

Income statement

Revenue$311.4M-1.5%

Gross profit$208.3M-2.9%

Operating income$75.5M+95.0%

Net income$51.0M+126%

EPS (diluted)$0.32+129%

Balance sheet

Cash & equivalents$209.8M+49.2%

Total debt$290.3M-31.4%

Total equity$2.1B+3.3%

Total assets$2.6B-3.5%

Cash flow

Operating cash flow$86.7M+111%

CapEx$9.1M-10.2%

Free cash flow$77.6M+150%

Valuation

Market cap$9.07B-11.8%

Enterprise value$9.15B-13.6%

P/E60.6×+13.6×

P/S7.5×-1.0×

Profitability

Gross margin65%-0.8pp

Operating margin14.2%-7.9pp

Net margin10.9%-6.7pp

FCF margin22.3%+4.0pp

Returns & leverage

Return on equity6.5%-3.9pp

Debt / equity0.1×-0.1×

Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Bio-Techne’s 10-K, filed August 29, 2016, on SEC EDGAR. View the filing →